胰岛素抵抗作为将ApoB/ApoA1与MAFLD联系起来的潜在媒介,但不是炎症
Mengying Yang1, Xiaoman Liu1, Qianqian Li1
1Department of Infectious Disease, Fuyang People's Hospital, Fuyang, Anhui, China.
Therapeutic advances in endocrinology and metabolism
|September 19, 2025
概括
胰岛素耐药性 (IR) 显著调解了阿波利波蛋白B/A1 (ApoB/A1) 与代谢相关脂肪肝疾病 (MAFLD) 之间的联系. 向IR可能比MAFLD进展的抗炎疗法更有效.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 脂质学 脂质学是指脂质学.
背景情况:
- 代谢相关的脂肪肝疾病 (MAFLD) 与胰岛素抵抗 (IR) 和炎症有关.
- 阿波蛋白B (ApoB) 和阿波蛋白A1 (ApoA1) 是非传统的脂质标记物,与MAFLD的关联不清楚,以及IR/炎症的作用.
研究的目的:
- 调查ApoB/A1,MAFLD之间的关联,以及IR和炎症的调解作用.
- 探索脂质代谢标志物与MAFLD风险之间的关系.
主要方法:
- 对1061名参与者的回顾性研究 (529名非MAFLD,532名MAFLD).
- 使用了后勤回归,斯皮尔曼相关性和调解分析.
- 评估的ApoB/A1,IR指数 (TyG,TyGBMI,METS-IR) 和炎症标志物.
主要成果:
- MAFLD组显示出更高的IR指数和炎症标志物.
- ApoB/A1,TyG,TyGBMI和METS-IR与MAFLD风险相关.
- 红外线指数 (TyG,TyGBMI,METS-IR) 显著调解了ApoB/A1和MAFLD之间的关联.
结论:
- 胰岛素抵抗 (IR) 是ApoB/A1和MAFLD之间的关键调解者,比全身炎症更重要.
- 针对IR的干预措施可能比MAFLD的抗炎疗法更有效.
- 澄清了脂质新陈代谢,IR,炎症和MAFLD之间的复杂相互作用.
更多相关视频
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
10.8K
09:20An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
4.2K
相关概念视频
01:38Inflammation
61.7K
Overview
61.7K
01:28Insulin: The Receptor and Signaling Pathways
2.8K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.8K
01:30Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
01:30Atherosclerosis I: Introduction
925
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
925
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:30Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314